image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
Filing Date
March 08, 2021
Document Date
March 02, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC